Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 17th May 2016
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD issues advice on babesiosis treatment
D reticulatus tick
Babesiosis was recently confirmed in Essex in four dogs with no history of foreign travel.
Potential concerns about treatment availability
 
In light of recent outbreaks of babesiosis in UK dogs, the Veterinary Medicines Directorate (VMD) has published a statement on the availability of treatments.

Babesiosis was recently confirmed in Essex in four dogs with no history of foreign travel. A tick survey in the area the dogs were walked has since revealed the presence of infected D reticulatus ticks.

There is currently no veterinary medicinal product (VMP) that is authorised in the UK for the treatment of babesiosis in dogs. Treatments must, therefore, be prescribed in accordance with the cascade. The use of a VMP authorised for use in a different species may be required. Alternatively, an EU authorised treatment for babesiosis in dogs may be imported.

The VMD says: 'Under the provisions of the cascade, vets may choose to use Imizol 85mg/ml solution for injection (active substance imidocarb), by Intervet, which is authorised in the UK for the treatment and prevention of bovine babesiosis (Babesia divergens).

'If, based on the the vets' professional judgement, this treatment is not suitable for a particular patient, then an alternative VMP can be imported instead.

'Products exist across the EU which vets may apply to import through the special import scheme. These include (but may not be limited to) imidocarb containing products similar to Imizol such Carbesia (MAH include MSD Animal health), which has dogs as a target species and includes dosing information for dogs.'

For queries related to importation, email importcert@vmd.defra.gsi.gov.uk and quote 'treatment for babesiosis in dogs' in the subject line.

Become a member or log in to add this story to your CPD history

FIVP announces third series of Practice Matters

News Story 1
 The Federation of Independent Veterinary Practices (FIVP) has announced a third season of its podcast, Practice Matters.

Hosted by Ian Wolstenholme, series three will focus on the Competition and Markets Authority (CMA) investigation, including a discussion about some of the expected impacts on independent veterinary colleagues.

Episode one launches on 13th January with guests Drs David Reader and Scott Summers, who will draw on their research into the CMA investigation and provide insights into themes such as transparency, pricing and consumer trust.

Ian Wolstenholme said: "In its third series, we will try and hone in on what the changes will mean in reality for independent practices with advice and guidance on implementation and delivery, drawing on the experience of our own team and other experts in the profession. Hope you can join us soon!" 

Click here for more...
News Shorts
Survey seeks ruminant sector views on antimicrobial stewardship

A new survey is seeking views of people working in the UK ruminant sector on how to tackle the challenge of demonstrating responsible antibiotic stewardship.

Forming part of a wider, collaborative initiative, the results will help identify the types of data available so that challenges with data collection can be better understood and addressed.

Anyone working in the UK farming sector, including vets and farmers,is encouraged to complete the survey, which is available at app.onlinesurveys.jisc.ac.uk